Heartpoint Global Inc.
Biotechnology company · Coral Gables, Florida, United States
Heartpoint Global Inc. is a biotechnology company headquartered in Coral Gables, Florida, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $3.3 million sold in a notice filed in 2020.
Heartpoint Global at a glance
What does Heartpoint Global do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.8 million in total (2025). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.3 million sold (2020).
Frequently asked questions about Heartpoint Global
Where is Heartpoint Global headquartered?
Heartpoint Global Inc. is headquartered in Coral Gables, Florida, United States.
What does Heartpoint Global do?
Heartpoint Global Inc. is a biotechnology company.
When was Heartpoint Global founded?
The earliest incorporation on record for Heartpoint Global Inc. is in 2018, according to public company registers.
Similar companies
- Adze Biotechnology IncCoral Gables, Florida, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences